| therapeutics | Asset | indications | discovery | non-clinical | clinical |
|---|---|---|---|---|---|
| Small molecules | CR-C003 | Autoimmune disease* | on | on | |
| CR-C00X | B-cell lymphoma | on | on | ||
| Gene therapy (Adeno-associated virus) | CR-G001 | HCC | on | on | |
| Therapeutic proteins | CR-T1~T4 | Autoimmune disease* | on | on |
* Our autoimmune disease treatment candidates are being developed as indications for psoriasis, psoriatic arthritis, rheumatoid arthritis and/or inflammatory bowel disease. Indications will be extended to ankylosing spondylitis and graft-versus-host disease on medical and experimental basis.